loadpatents
name:-0.04065203666687
name:-0.025158166885376
name:-0.0040631294250488
Barberis; Alcide Patent Filings

Barberis; Alcide

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barberis; Alcide.The latest application filed is for "immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same".

Company Profile
3.27.30
  • Barberis; Alcide - Zurich CH
  • Barberis; Alcide - Bellinzona CH
  • Barberis; Alcide - Bioggio CH
  • Barberis; Alcide - Uitikon CH
  • Barberis; Alcide - Olivone CH
  • Barberis; Alcide - Breganzona CH
  • Barberis; Alcide - Zuerich CH
  • Barberis; Alcide - Zurisch CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunoglobulin Frameworks Which Demonstrate Enhanced Stability In The Intracellular Environment And Methods Of Identifying Same
App 20200165322 - Tissot; Kathrin ;   et al.
2020-05-28
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
Grant 10,570,190 - Tissot , et al. Feb
2020-02-25
Immunoglobulin Frameworks Which Demonstrate Enhanced Stability In The Intracellular Environment And Methods Of Identifying Same
App 20190119361 - Tissot; Kathrin ;   et al.
2019-04-25
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
Grant 10,125,186 - Tissot , et al. November 13, 2
2018-11-13
Stable and soluble antibodies inhibiting TNF.alpha.
Grant 9,683,034 - Ewert , et al. June 20, 2
2017-06-20
Immunoglobulin Frameworks Which Demonstrate Enhanced Stability In The Intracellular Environment And Methods Of Identifying Same
App 20170107272 - Tissot; Kathrin ;   et al.
2017-04-20
Phospholipid drug analogs
Grant 9,540,407 - Maj , et al. January 10, 2
2017-01-10
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
Grant 9,518,108 - Tissot , et al. December 13, 2
2016-12-13
Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Grant 9,512,411 - Auf Der Maur , et al. December 6, 2
2016-12-06
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20160185850 - Ewert; Stefan ;   et al.
2016-06-30
Stable and soluble antibodies inhibiting TNF alpha
Grant 9,315,572 - Ewert , et al. April 19, 2
2016-04-19
Phospholipid Drug Analogs
App 20160090395 - MAJ; Roberto ;   et al.
2016-03-31
Phospholipid drug analogs
Grant 9,180,183 - Maj , et al. November 10, 2
2015-11-10
Phospholipid drug analogs
Grant 9,173,935 - Maj , et al. November 3, 2
2015-11-03
Phospholipid drug analogs
Grant 9,173,936 - Maj , et al. November 3, 2
2015-11-03
Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase Alk
App 20150203829 - Auf Der Maur; Adrian ;   et al.
2015-07-23
Phospholipid drug analogs
Grant 9,050,319 - Maj , et al. June 9, 2
2015-06-09
Immunoglobulin Frameworks Which Demonstrate Enhanced Stability In The Intracellular Environment And Methods Of Identifying Same
App 20150057191 - Tissot; Kathrin ;   et al.
2015-02-26
Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Grant 8,945,563 - Auf Der Maur , et al. February 3, 2
2015-02-03
scFv antibodies which pass epithelial and/or endothelial layers
Grant 8,936,785 - Auf Der Maur , et al. January 20, 2
2015-01-20
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
Grant 8,853,362 - Tissot , et al. October 7, 2
2014-10-07
scFv Antibodies Which Pass Epithelial and/or Endothelial Layers
App 20140234315 - Auf Der Maur; Adrian ;   et al.
2014-08-21
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20140171634 - Ewert; Stefan ;   et al.
2014-06-19
Stable and soluble antibodies inhibiting TNF.alpha.
Grant 8,691,228 - Ewert , et al. April 8, 2
2014-04-08
Phospholipid Drug Analogs
App 20130273144 - Maj; Roberto ;   et al.
2013-10-17
Phospholipid Drug Analogs
App 20130267481 - Maj; Roberto ;   et al.
2013-10-10
Phospholipid Drug Analogs
App 20130266635 - Maj; Roberto ;   et al.
2013-10-10
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20130171143 - Ewert; Stefan ;   et al.
2013-07-04
Stable and soluble antibodies inhibiting TNF.alpha.
Grant 8,389,693 - Ewert , et al. March 5, 2
2013-03-05
Treatment Of Conditions By Toll-like Receptor Modulators
App 20120083473 - Holldack; Johanna ;   et al.
2012-04-05
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20120064077 - Ewert; Stefan ;   et al.
2012-03-15
Phospholipid Drug Analogs
App 20120009247 - Maj; Roberto ;   et al.
2012-01-12
Methods For Inducing An Immune Response
App 20120003298 - Barberis; Alcide ;   et al.
2012-01-05
Stable and soluble antibodies inhibiting TNF.alpha.
Grant 8,067,547 - Ewert , et al. November 29, 2
2011-11-29
Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK
App 20110159008 - Auf Der Maur; Adrian ;   et al.
2011-06-30
Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Grant 7,902,340 - Auf Der Maur , et al. March 8, 2
2011-03-08
Scfv Antibodies Which Pass Epithelial And/or Endothelial Layers
App 20090311251 - Auf Der Maur; Adrian ;   et al.
2009-12-17
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20090263382 - Ewert; Stefan ;   et al.
2009-10-22
Method for the identification and/or validation of receptor tyrosine kinase inhibitors
Grant 7,566,528 - Gunde , et al. July 28, 2
2009-07-28
Genetic Selection System To Identify Proteases, Protease Substrates And Protease Inhibitors
App 20090029369 - Cottier; Valerie ;   et al.
2009-01-29
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
App 20080233110 - Auf Der Maur; Adrian ;   et al.
2008-09-25
Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
App 20080118512 - Auf Der Maur; Adrian ;   et al.
2008-05-22
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
Grant 7,258,986 - Auf Der Maur , et al. August 21, 2
2007-08-21
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
Grant 7,258,985 - Maur , et al. August 21, 2
2007-08-21
Protein kinase inhibitors
App 20070149535 - Berset; Catherine ;   et al.
2007-06-28
Method for the identification of modulators of a secretase activity
App 20060068388 - Barberis; Alcide ;   et al.
2006-03-30
Immunoglobulin frameworks which demonstrate enhanced statbility in the intracellular envioronment and methods of identifying same
App 20060035320 - Tissot; Kathrin ;   et al.
2006-02-16
Method for identifying protein-protein interactions
App 20060019238 - Urech; David M. ;   et al.
2006-01-26
Method for the identification and/or validation of receptor tyrosine kinase inhibitors
App 20050239049 - Gunde, Tea ;   et al.
2005-10-27
Screening system
Grant 6,821,728 - Escher , et al. November 23, 2
2004-11-23
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
App 20030096306 - Maur, Adrian Auf Der ;   et al.
2003-05-22
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
App 20010024831 - Der Maur, Adrian Auf ;   et al.
2001-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed